Home › NCT06211348

Genomic Sequencing in Anatomically Normal Fetuses

Who can join

Ages 18 to 64 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

Pregnant patients who are:

* Pregnant with a structurally normal fetus (singleton or multiple gestation)
* Planning to undergo prenatal diagnosis by either chorionic villus sampling or amniocentesis with chromosome microarray analysis for routine indications
* Planning, or have already completed expanded carrier screening

Exclusion Criteria:

Pregnant patients who:

* Decline prenatal diagnostic testing
* Are pregnant and their fetus has a known anomaly
* Declined chromosomal microarray analysis of expanded carrier screening

About the study

This cohort study will examine the clinical utility of genomic sequencing (GS) in patients undergoing prenatal diagnostic procedures (chorionic villus sampling or amniocentesis) for routine indications other than a structural fetal anomaly.

What is being tested

• Genomic Sequencing (device)

Sponsor: University of California, San Francisco · Participants: 1,000 · Started: Jan 1, 2024

Contact the study team

• Nuriye Sahin Hodoglugil, DrPH · Phone: 415-353-3400

Official record on ClinicalTrials.gov — NCT06211348

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.